APELLIS PHARMACEUTICALS INC's ticker is and the CUSIP is 03753U906. A total of 6 filers reported holding APELLIS PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $33,456,180 | +101.0% | 879,500 | +381.4% | 0.01% | +83.3% |
| Q2 2023 | $16,643,970 | -2.6% | 182,700 | -29.5% | 0.01% | -14.3% |
| Q1 2023 | $17,096,832 | +0.6% | 259,200 | -21.1% | 0.01% | -12.5% |
| Q4 2022 | $16,997,077 | -29.8% | 328,700 | -7.3% | 0.01% | -27.3% |
| Q3 2022 | $24,219,000 | +260.7% | 354,600 | +138.8% | 0.01% | +266.7% |
| Q2 2022 | $6,715,000 | – | 148,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GROUP ONE TRADING, L.P. | 74,100 | $1,985,000 | 0.02% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| SIMPLEX TRADING, LLC | 77 | $206,000 | 0.00% |